Add to Favourites
To login click here
Asensus Surgical (formerly TransEnterix) announced its operating and financial results for the fourth quarter and full year 2022. The company saw strong adoption and utilization trends of their Senhance product, and made significant progress in the development of their Performance-Guided Surgery technology. They also hosted an Investor Day on February 21, 2023 to provide an in-depth review of their business.